Colorectal cancer (CRC) diagnosis rates declined in 2020 and returned to pre-pandemic levels in 2021 among the cancers ...

During the first fireside chat at the Patient-Centered Oncology Care® meeting, Alyssa Schatz, MSW, of National Comprehensive ...

US drug authorities are allowing 24% more production of Vyvanse, an ADHD drug from Takeda Pharmaceutical Co. and generic ...

The U.S. Drug Enforcement Administration (DEA) has increased the production limit for Takeda Pharmaceutical's ADHD drug ...

STAT's podcast The Readout Loud discusses Summit's cancer immunotherapy, the company's co-CEO, Moderna's spending cuts and ...

Your donation makes it possible for us ... cancer treatment started earlier this year because she couldn't get coverage for the amount her doctor requested. Then she got a letter telling her the ...

A new therapy approved by the FDA is one of the first major brain tumor breakthroughs in decades, say neuro-oncologists.

Supply and manufacturing issues with multiple ADHD medications have caused a years-long shortage that has coincided with an ...

Thus, the US FDA is thinking of allowing the temporary import of chemotherapy drugs from manufacturers that do not have clearance in the United States due to a shortage of over a dozen cancer ...

ADHD drugs have been in short supply for multiple years. Back in Oct. 2022, the U.S. Food and Drug Administration officially announced a shortage of the ADHD treatment Adderall due to a ...